LGALS3 and diabetes mellitus: Thus, clarifying the potential pathogenic mechanism of Galectin-3 in diabetes and diabetic complications will provide a basis for finding new biomarkers for precision disease prediction and early-diagnosis, and developing potential therapeutic targets.